Ascletis Pharma Inc. (1672.HK)

HKD 2.55

(-10.21%)

Inventory Summary of Ascletis Pharma Inc.

Ascletis Pharma Inc.'s latest annual inventory in 2023 was 6.07 Million CNY , down -70.41% from previous year.
Ascletis Pharma Inc.'s latest quarterly inventory in 2024 Q2 was 6.48 Million CNY , down 0.0% from previous quarter.
Ascletis Pharma Inc. reported annual inventory of 20.51 Million CNY in 2022, down -63.51% from previous year.
Ascletis Pharma Inc. reported annual inventory of 56.23 Million CNY in 2021, down -4.52% from previous year.
Ascletis Pharma Inc. reported quarterly inventory of 6.48 Million CNY for 2024 Q1, up 6.8% from previous quarter.
Ascletis Pharma Inc. reported quarterly inventory of 27.41 Million CNY for 2023 Q1, up 33.61% from previous quarter.

Annual Inventory Chart of Ascletis Pharma Inc. (2023 - 2016)

Historical Annual Inventory of Ascletis Pharma Inc. (2023 - 2016)

Year	Inventory	Inventory Growth
2023	6.07 Million CNY	-70.41%
2022	20.51 Million CNY	-63.51%
2021	56.23 Million CNY	-4.52%
2020	58.89 Million CNY	-31.55%
2019	86.03 Million CNY	2.58%
2018	83.87 Million CNY	34.83%
2017	62.21 Million CNY	231.85%
2016	18.74 Million CNY	0.0%

Year	Inventory	Inventory Growth
2024 Q2	6.48 Million CNY	0.0%
2024 Q1	6.48 Million CNY	6.8%
2023 Q1	27.41 Million CNY	33.61%
2023 FY	6.07 Million CNY	-70.41%
2023 Q4	6.07 Million CNY	0.0%
2023 Q3	6.07 Million CNY	-77.86%
2023 Q2	27.41 Million CNY	0.0%
2022 Q3	20.51 Million CNY	-67.43%
2022 Q2	63 Million CNY	0.0%
2022 Q1	63 Million CNY	12.04%
2022 Q4	20.51 Million CNY	0.0%
2022 FY	20.51 Million CNY	-63.51%
2021 FY	56.23 Million CNY	-4.52%
2021 Q3	56.23 Million CNY	51.28%
2021 Q4	56.23 Million CNY	0.0%
2021 Q1	37.17 Million CNY	-36.88%
2021 Q2	37.17 Million CNY	0.0%
2020 Q2	81.73 Million CNY	0.0%
2020 Q3	58.89 Million CNY	-27.94%
2020 Q4	58.89 Million CNY	0.0%
2020 Q1	81.73 Million CNY	-5.0%
2020 FY	58.89 Million CNY	-31.55%
2019 Q1	86.5 Million CNY	3.13%
2019 FY	86.03 Million CNY	2.58%
2019 Q4	86.03 Million CNY	0.0%
2019 Q3	86.03 Million CNY	-0.54%
2019 Q2	86.5 Million CNY	0.0%
2018 Q1	69.18 Million CNY	11.22%
2018 FY	83.87 Million CNY	34.83%
2018 Q4	83.87 Million CNY	0.0%
2018 Q3	83.87 Million CNY	16.38%
2018 Q2	72.07 Million CNY	4.17%
2017 FY	62.21 Million CNY	231.85%
2017 Q1	- CNY	0.0%
2017 Q3	62.21 Million CNY	0.0%
2017 Q4	62.21 Million CNY	0.0%
2016 FY	18.74 Million CNY	0.0%

Peer Inventory Comparison of Ascletis Pharma Inc.

Name	Inventory	Inventory Difference
Uni-Bio Science Group Limited	36.39 Million HKD	83.318%
CK Life Sciences Int'l., (Holdings) Inc.	1.2 Billion HKD	99.496%